FindTrial
Sign In

Treatment of conditions in cancer patients with drugs that have not been approved for such use .

Off-label prescribing practices in patients with cancer receiving palliative care in an inpatient setting- a prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067716
Enrollment
488
Registered
2024-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Control Intervention1: NIL as it is an observational study: NIL as it is an observational study

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients with cancer 2. Admitted as inpatients 3.Directly under the care of Palliative Medicine or seen by Palliative medicine as consult. 4. Receiving pharmacotherapy for symptom management where symptoms are due to the illness or illness -related complication

Exclusion criteria

Exclusion criteria: Patients consulted for acute symptom management in a post- operative or post procedure setting

Design outcomes

Primary

MeasureTime frame
Frequency of off label use by therapeutic drug class and associated evidence b) Frequency of off label use by drug and associated evidence c) Clinical Indications treated with off-label drugs and the most frequently used off-label drugs for them. Timepoint: At the end of 18th month of the study—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactAditi Malik

Kasturba Medical College, Manipal

smtshenoy@gmail.com9844559772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026